MetaCap

Damora Therapeutics Statistics

NASDAQ: DMRAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

23.22-1.08 (-4.44%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Damora Therapeutics by the numbers

Damora Therapeutics has a market capitalization of $1.44 billion based on 61.90M shares outstanding. Its trailing P/E ratio is 13.6, above the 3-company peer median of 7.2. The stock trades 7.0% above its 50-day average and 8.7% below its 200-day average.

Average daily trading volume is 584.28K shares, or about $13.6 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

DMRA valuation vs. peer median

DMRA compared with the median of 8 peer companies
MetricDMRAPeer medianDifference
Market cap$1.44B$1.41B+2%
P/E (TTM)13.67.2+90%
Avg. volume584.28K965.94K-40%

Peer median across 8 companies: KLRA, SRPT, ADRX, NRIX, TYRA, ANAB, RAPP, PGEN.

Valuation

Price and trading

Previous close
24.30
Open
23.81
Day range
23.13 – 24.51
52-week range
15.76 – 38.33
52-week change
+38.46%
Beta
—
Volume
643.38K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
1.44B
Pe
13.58
Forward Pe
-10.63
Eps
1.71
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
38.33
Week52 Low
15.76
Avg Volume
584.28K
Shares Outstanding
61.90M
Ma50
21.70
Ma200
25.44
Earnings Date
Nov 4, 2026
Pct From52w High
-39.41%
Pct From52w Low
47.34%

Related